How is the Spruce Biosciences Inc today?

The Spruce Biosciences Inc today is trading in the down by 0.00% at 0.07.

How has Spruce Biosciences Inc performed historically?

The Spruce Biosciences Inc is currently trading down 0.00% on an intraday basis in the past week the index fell -12.50%. The index has been down -82.50% in the past quarter and fell -90.67% in the past year. You can view this in the overview section.

What is Spruce Biosciences Inc Annual Revenue?

Spruce Biosciences Inc Annual Revenue fell 51.32%, in the last year to $4.91 M. Its sector's average revenue growth for the last fiscal year was 7.53%.

What is Spruce Biosciences Inc Annual Net Profit?

Spruce Biosciences Inc Annual Net Profit fell 10.68% in the last year to $53.04 M. Its sector's average net profit growth for the last fiscal year was -31.39%.

What is Spruce Biosciences Inc Price to Earning Ratio?

Spruce Biosciences Inc Price to Earning Ratio is -0.06, which is negative.

What is Spruce Biosciences Inc Stock Price?

Spruce Biosciences Inc Stock Price fell 90.67% and underperformed its sector by 95.77% in the past year.

What is Spruce Biosciences Inc Quarterly Revenue?

Spruce Biosciences Inc Quarterly Revenue fell 75.86% YoY to $0.7 M. Its sector's average revenue growth YoY for the quarter was 5.23%.

What is Spruce Biosciences Inc Quarterly Net profit?

Spruce Biosciences Inc Quarterly Net profit fell 136.77% YoY to $23.56 M. Its sector's average net profit growth YoY for the quarter was -29.17%.

What is Spruce Biosciences Inc Debt to Equity Ratio?

Spruce Biosciences Inc Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Spruce Biosciences Inc Return on Equity(ROE)?

Spruce Biosciences Inc Return on Equity(ROE) for the last financial year was -100.7%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Spruce Biosciences Inc Mutual Fund Holding?

Spruce Biosciences Inc Mutual Fund Holding decreased by 0.06% in the last quarter to 4.96.

What is Spruce Biosciences Inc Interest Coverage Ratio?

Spruce Biosciences Inc Interest Coverage Ratio is -171.76, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Spruce Biosciences Inc Institutional Holding?

Spruce Biosciences Inc Institutional Holding decreased by 0% in the last quarter to 35.45.

Spruce Biosciences Inc XNAS: SPRB

Spruce Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Spruce Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Spruce Biosciences Inc
Rating: 1.12883325
Author: Trendlyne DVM scores

about

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT)...

0.07 0.00 (0.00%)

New 52W Low in past week

673.3K XNAS Volume

XNAS 06 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Spruce Biosciences Inc is on 13 May 2025 for the purpose of Spruce Biosciences Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Mid Valuation

31.3 / 100

Technically Bearish

13.8 / 100

1Yr Price target upside is 971%

2 analysts

Spruce Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spruce Biosciences Inc Live Share Price Today, Share Analysis and Chart

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT)...

New 52W Low in past week

SWOT Analysis

Spruce Biosciences Inc Live Price Chart

Spruce Biosciences Inc FAQ

How is Spruce Biosciences Inc today?

Spruce Biosciences Inc today is trading in the red, and is down by 0.00% at 0.07.

How has Spruce Biosciences Inc performed historically?

Spruce Biosciences Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -12.50%. stock has been down -82.50% in the past quarter and fell -90.67% in the past year. You can view this in the overview section.